Literature DB >> 2815961

[Weaknesses of conventional drainage systems].

A Härle1.   

Abstract

Of the different drainage systems the high vacuum technique according to Redon is the procedure of choice for orthopaedic and trauma surgery. Overflow drainage should be restricted to certain special indications, when there is a risk for high blood loss. Open drainage doesn't fulfill the high sterility demands, we require in orthopaedic surgery. Aside from the positive wound healing effects, high vacuum drainage according to Redon hides some risks for complications, which aren't well known by surgeons. All openings of the drainage lines, the change of suction container as well, may lead to a reflux and thus cause retrograde wound contamination. By this procedure also aerosol formation was found, which may represent risks for the ward personnel. Changes of the suction container must have an indication and should only be performed in the presence of a blocking device at the connection tube. The vacuum indicators of most products on the market need further improvement, in order to enhance the operating safety.

Entities:  

Mesh:

Year:  1989        PMID: 2815961     DOI: 10.1055/s-2008-1044717

Source DB:  PubMed          Journal:  Z Orthop Ihre Grenzgeb        ISSN: 0044-3220


  3 in total

1.  [Pressure-volume analysis of wound suction drainage containers and suction capacity of drainage tubes].

Authors:  C Mohadjer; R Siegert; H Jäger; H Weidauer
Journal:  Langenbecks Arch Chir       Date:  1994

2.  [Gravity or suction drainage in thyroid surgery? Control of efficacy with ultrasound determination of residual hematoma].

Authors:  W Schwarz; C Willy; C Ndjee
Journal:  Langenbecks Arch Chir       Date:  1996

3.  Aprotinin and classic wound drainage are unnecessary in total hip replacement - a prospective randomized trial.

Authors:  F Fleischmann; C Matuschek; K Orth; P A Gerber; R Mota; W T Knoefel; M Peiper; M Schick; M van Griensven; Edwin Bölke; W Fleischmann
Journal:  Eur J Med Res       Date:  2011-01-27       Impact factor: 2.175

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.